跳至主要内容
临床试验/NCT06394089
NCT06394089招募中不适用

Effect of Degenerative Spondylolisthesis on the Clinical Outcome of Unilateral Biportal Endoscopy for Lumbar Spinal Stenosis: a Single-center, Prospective Cohort Trial Protocol

Beijing Friendship Hospital1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2024年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
1
主要终点
Oswestry Disability Index (ODI)

研究概览

简要总结

A single-center, prospective cohort trial aims to provide stronger evidence regarding the impact of degenerative spondylolisthesis on the clinical outcome of unilateral biportal endoscopy for lumbar spinal stenosis

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age range: 50-80 years
  • Diagnosis of LSS affecting 1-2 vertebral levels
  • Predominant manifestation of neurogenic intermittent claudication, with ineffective conservative treatment for at least 3 months
  • Presence of lumbar DS of less than grade II and absence of spine instability
  • Willingness to participate in the study and complete follow-up assessments.

排除标准

  • Diagnosis of isthmic lumbar spondylolisthesis or lumbar DS of grade ≥II
  • Evidence of instability at the affected vertebral level (intervertebral angle change > 15° and/or vertebral translation ≥ 4.5 mm in standing flexion-extension radiographs of the lumbar spine)
  • History of prior surgery at the affected vertebral level
  • Presence of scoliosis with a Cobb angle >20º
  • Presence of other conditions affecting the lumbar spine (infection, tumor, fracture, neurological diseases, and others)
  • Medical disorders that preclude surgical tolerance
  • Participation in other clinical research projects related to the treatment of lumbar spinal stenosis.

结局指标

主要结局

Oswestry Disability Index (ODI)

时间窗: From enrollment to the end of follow-up at 2 year

0-100%, the higher the score, the more severe the lumbar spine dysfunction

次要结局

  • White blood cell count(From enrollment to 3 days after surgery)
  • Creatine kinase level(From enrollment to 3 days after surgery)
  • Lactate dehydrogenase level(From enrollment to 3 days after surgery)
  • Myoglobin level(From enrollment to 3 days after surgery)
  • X-ray(From enrollment to the end of follow-up at 2 year)
  • Computed tomography (CT) scan(From enrollment to the end of follow-up at 2 year)
  • Magnetic resonance imaging (MRI)(From enrollment to the end of follow-up at 2 year)
  • Surgical complication(From enrollment to the end of follow-up at 2 year)
  • Visual analog scale (VAS) score for lower back pain(From enrollment to the end of follow-up at 2 year)
  • Visual analog scale (VAS) score for leg pain(From enrollment to the end of follow-up at 2 year)
  • Operative time(Immediately after the surgery)
  • Intraoperative blood loss(Immediately after the surgery)
  • Postoperative hospital stays(Immediately after the discharge)
  • Japanese Orthopaedic Association (JOA) score(From enrollment to the end of follow-up at 2 year)
  • Modified MacNab criteria(From enrollment to the end of follow-up at 2 year)
  • Improvement ratio of Visual analog scale (VAS) score for lower back pain(From enrollment to the end of follow-up at 2 year)
  • Improvement ratio of Visual analog scale (VAS) score for leg pain(From enrollment to the end of follow-up at 2 year)
  • Improvement ratio of Japanese Orthopaedic Association (JOA) score(From enrollment to the end of follow-up at 2 year)
  • Improvement ratio of Oswestry Disability Index (ODI)(From enrollment to the end of follow-up at 2 year)
  • Percentage of neutrophils (N%)(From enrollment to 3 days after surgery)
  • C-reactive protein level(From enrollment to 3 days after surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验